Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 10/20 | 0.51 |
| ▸ | ITGA2B | P08514 | 9/20 | 0.51 |
| ▸ | ITGAV | P06756 | 1/20 | 0.49 |
| ▸ | CTSL | P07711 | 2/20 | 0.48 |
| ▸ | CTSB | P07858 | 2/20 | 0.48 |
| ▸ | CTSS | P25774 | 2/20 | 0.48 |
| ▸ | TACR1 | P25103 | 2/20 | 0.47 |
| ▸ | TYR | P14679 | 1/20 | 0.47 |
| ▸ | CTSK | P43235 | 1/20 | 0.47 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.46 |
| ▸ | ITGB7 | P26010 | 1/20 | 0.46 |
| ▸ | PPARG | P37231 | 1/20 | 0.46 |
| ▸ | PPARA | Q07869 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18114620 | 0.90 | ITGB3 (0.53) | ITGB3ITGA2BITGAVCTSLCTSB | |
| SCHEMBL7263023 | 0.88 | CTSL (0.46) | ITGB3ITGA2BCTSLCTSBCTSS | |
| SCHEMBL14562452 | 0.88 | ITGA4 (0.56) | ITGB3ITGA2BITGAVCTSLCTSB | |
| SCHEMBL14562475 | 0.88 | ITGA4 (0.56) | ITGB3ITGA2BITGAVCTSLCTSB | |
| SCHEMBL8586541 | 0.84 | FOLH1 (0.58) | ITGB3ITGA2BITGAVCTSLCTSB | |
| SCHEMBL7258215 | 0.82 | NR1I2 (0.56) | PPARGALOX15 | |
| SCHEMBL11747900 | 0.82 | ITGB3 (0.65) | ITGB3ITGA2BITGAVCTSLCTSB | |
| SCHEMBL9157537 | 0.82 | ITGB3 (0.65) | ITGB3ITGA2BITGAVCTSLCTSB | |
| SCHEMBL9636970 | 0.82 | ITGB3 (0.65) | ITGB3ITGA2BITGAVCTSLCTSB | |
| SCHEMBL8582379 | 0.82 | CTSL (0.55) | ITGB3ITGA2BITGAVCTSLCTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6140100-A | CONJUGATE POLYPEPTIDE WHICH IS TISSUE PREFERENTIAL; ANTICARCINOGENIC AGENTS | GLAXO WELLCOME INC. (US) | 2000-10-31 | — | — | US | disclosed |